AIM IMMUNOTECH INC. Shareholders' Equity
AIM IMMUNOTECH INC. (AIM) had Shareholders' Equity of $7.74 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.13M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$9.78M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$6.08M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $7.74M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.13M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | -$9.78M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | -$6.08M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | -$6.55M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | -$3.86M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | -$1.32M 10-Q · filed 2026-08-07 | |
| 2024-12-11 | $6.00M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $2.91M 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $6.10M 10-Q · filed 2025-11-17 | |
| 2024-03-31 | $4.83M 10-Q · filed 2025-11-17 | |
| 2023-12-31 | $10.23M 10-K · filed 2026-03-27 | |
| 2023-09-30 | $22.60M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $30.14M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $34.99M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $38.47M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $42.70M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $48.78M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $53.30M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $56.88M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $62.05M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $65.53M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $70.97M 10-Q · filed 2022-11-14 | $70.97M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $61.29M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $61.11M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $46.99M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $35.13M 10-Q · filed 2021-11-15 | $35.11M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $13.44M 10-K · filed 2022-03-31 | $12.91M 10-K · filed 2020-03-30 |
| 2019-09-30 | $13.44M 10-K · filed 2021-03-31 | $13.84M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $6.55M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $3.93M 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $5.58M 10-K · filed 2021-03-31 | $5.17M 10-K · filed 2019-04-01 |
| 2018-09-30 | $6.44M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $9.10M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $10.20M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $8.70M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $10.04M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.33M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $12.95M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $15.50M 10-K · filed 2019-04-01 | |
| 2016-09-30 | $16.63M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $17.49M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $18.41M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.37M 10-K · filed 2018-03-30 | |
| 2014-12-31 | $25.00M 10-K · filed 2018-03-30 | |
| 2013-12-31 | $29.30M 10-K · filed 2017-03-31 | |
| 2012-12-31 | $44.70M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |